PhRMA revises guidelines for clinical trials
Pharma Compliance Alert, April 29, 2009
Pharmaceutical companies should provide results summaries for all interventional clinical trials involving patients, according to revised industry guidance.
Companies should publish the summaries whether the FDA approves the medicines or the particular research programs have been discontinued
Read more about PhRMA's revised guidelines for clinical trials.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Medicare & Reimbursement Advisor Weekly
This electronic newsletter from ePharmaceuticalsT delivers weekly, first-hand reports of marketplace responses to Medicare...
Most Popular
- Articles
-
- Q/A: May we bill an E/M code for a wound care first visit
- Peer Review Monthly: Do you know what I know?
- New, more deadly strain of MRSA found
- 2010 ICD-9 code updates now available online
- Omnicare to pay $98 million to settle kickback charges
- Eliminate missed charges, errors to reduce lost revenue
- Study: Action can be taken to reduce dementia risk
- Texas Hospital group pays U.S. $27.5 million in false claims settlement
- Understand the H1N1 Flu and how to code it
- Tamiflu ® shortage sparks dosing confusion at some facilities
- E-mailed
-
- Q/A: May we bill an E/M code for a wound care first visit
- New, more deadly strain of MRSA found
- Omnicare to pay $98 million to settle kickback charges
- Peer Review Monthly: Do you know what I know?
- Eliminate missed charges, errors to reduce lost revenue
- Medicare patients suffer from a medical error every 1.7 minutes
- QA:Coding multiple initial infusions
- Study: Action can be taken to reduce dementia risk
- Texas Hospital group pays U.S. $27.5 million in false claims settlement
- Develop effective strategies for your breach notification response program
- Searched